Trials / Withdrawn
WithdrawnNCT02522143
College Students Who Self-Harm
College Students Who Self-Harm: An Intervention Study
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years – 27 Years
- Healthy volunteers
- Not accepted
Summary
Study Aims/Objectives: This projects' Primary Aim is development of a Condensed DBT Stepped Care Model tailored to the unique requirements of students meeting sub-clinical diagnostic criteria for BPD (Borderline Personality Disorder) with its associated high rate of self-harm and suicide.
Detailed description
Study Aims/Objectives: This projects' Primary Aim is development of a Condensed DBT Stepped Care Model tailored to the unique requirements of students meeting sub-clinical diagnostic criteria for BPD with its associated high rate of self-harm and suicide. The investigator previously implemented a 4-mth condensed-DBT regimen with success in an adult clinical population. This study will evaluate an intensive 8 week intervention formulated for students to reduce the high prevalence of self-harm and dysfunctional behavior in this population and reduce the need for extended treatment in later years. It will include rigorous screening for collateral disorders, including Substance Use Disorders exacerbating BPD symptoms and suicide risk.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Informational sessions describing BPD characteristics | Control intervention consists of informational sessions describing BPD characteristics/ treatment and time- / stress-management skills |
| BEHAVIORAL | Condensed-DBT treatment intervention | The Intervention consists of an 8-week manual based psychoeducational group utilizing modified condensed-DBT Treatment manual previously used in a treatment study (Moen et al, 2012). |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2015-08-13
- Last updated
- 2017-06-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02522143. Inclusion in this directory is not an endorsement.